Berg et al. establish a panel of patient-derived endometrial cancer organoids and xenograft models. They show that their models recapitulate the genetic profile of the donor tumor and can be used for drug testing and development of a prognostic gene signature.
- Hege F. Berg
- Marta Espevold Hjelmeland
- Camilla Krakstad
